A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects.
暂无分享，去创建一个
J. Lambert | M. Mulligan | W. Koff | J. Mestecky | K. Weinhold | Z. Moldoveanu | P. Fast | B. Forrest | M. Keefer | D. Schwartz | R. Hsieh | C. Smith